Navigation For Mobile

Category Archives: small molecule

NCEs Versus Generics – Adjusting Project Tactics & Objectives to Maximize Success

Since generic drugs are – on average – 20 to 90% cheaper than innovator drugs (or NCEs), the market for generics has grown considerably in recent years as a means…

Posted in Contract Manufacturing, drugs, generic, NCE, process chemistry, small molecule, synthesis, Synthesis Route | Comments Off on NCEs Versus Generics – Adjusting Project Tactics & Objectives to Maximize Success

Green Chemistry and Benign by Design

7 ways to boost profits and reduce pharma synthesis waste At Neuland, we’re advocates of green chemistry. Not only is it better for the environment, but it’s also just logistically…

Posted in analytical science, API synthesis, APIs, atom economy, Benign-by-Design, Capabilities, Chemistry, CMC, Contract Manufacturing, EHS, energy conservation, energy effciency, green chemistry, ICH, Impurity profile, Quality, R&D, Route Design, Route Scouting, small molecule, synthesis, Synthesis Route, Uncategorized, zero liquid discharge | Comments Off on Green Chemistry and Benign by Design

APIs – Continued Growth, Increasing Complexity

I was interviewed back in April for a Pharmaceutical Technology (PharmTech) article about demand drivers for small-molecule APIs. The article by Agnes Shanley – Pharma APIs:  It’s Still a Small…

Posted in API synthesis, APIs, Pharm Tech, Pharmaceutical Technology, QbD, small molecule | Comments Off on APIs – Continued Growth, Increasing Complexity